Skip to search.
 TSX Up 0.54% TSX Ventures Up 0.90%

VIVUS Inc. (VVUS)

-NasdaqGS
1.77 Down 0.04(2.20%) 9:37AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:1.81
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.50
Beta:1.48
Next Earnings Date:30-Jul-15VVUS Earnings announcement
Day's Range:1.77 - 1.85
52wk Range:1.61 - 5.13
Volume:82,489
Avg Vol (3m):1,001,970
Market Cap:183.76M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSDown 2.20%183.76M
LLYUp 0.20%90.92B
GSKUp 2.40%103.14B
PFEUp 0.68%219.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.84
Quarterly EPS Est (Jun-15) :-0.24
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-2.63

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback